Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People with confirmed lung cancer who need an EBUS-TBNA procedure (a type of camera test of the airways used to examine lymph nodes) as part of their cancer staging before receiving a specific type of radiation treatment called SBRT
- People with a general health and activity level that falls within a certain acceptable range, as measured by a standard medical scoring system (WHO/ECOG score of 0–2) (confirm with trial site)
- People whose lung cancer has been confirmed as a specific type called non-small cell lung cancer, through a tissue or cell sample
- People whose cancer is at an early stage (T1–T2) with no signs that it has spread to other parts of the body
- People who have had both a CT scan and a PET scan as part of their assessments
- People whose medical condition means surgery is not a safe option for them
- People who have chosen not to have surgery
Who may not be able to join:
- People considered by their doctors to be medically unfit to safely undergo a bronchoscopy (a camera examination of the airways)
- People who have an active infection in their body, lungs, or around the heart
- People who are pregnant or breastfeeding
- People whose treatment plan includes conventional radiotherapy, chemotherapy, biological therapy, vaccine therapy, or surgery (except if the disease gets worse later)
- People who are not able to give their informed consent to take part
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To test whether or not there is a difference in accuracy between CT/PET and the minimally invasive technique of EBUS-TBNA for mediastinal staging in patients with non-small cell lung cancer prior to stereotactic body radiotherapy (SBRT).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.